Response Biomedical Corporation COO steps down

Duane Morris, the chief operating officer of Response Biomedical Corporation, has announced that he is resigning from his position effective October 29, a position he has held for the past four years.

Response Biomedical, a maker of onsite biodefense testing equipment, has begun a major process of restructuring and refocusing on the growth of its cardiovascular sector. The company, according to, has come to the conclusion that the role of COO is no longer appropriate.

“The numerous contributions made by Mr. Morris during his tenure at Response are much appreciated by management and the Board,” CEO S. Wayne Kay said, according to “We thank him for his leadership and wish him well in his future endeavors.”

The corporation is known for developing, producing and marketing rapid onsite diagnostic tests for use with what is known as its RAMP platform. RAMP is used for both point of care and laboratory testing.

Non-clinically, RAMP tests exist for a variety of biodefense applications, including on-site detection of anthrax, smallpox, ricin and botulinum toxin. Clinical test have been made commercially available for the early detection of heart attacks, congestive heart failure, influenza and human respiratory syncytial virus.

The RAMP system consists of a reader and single-use disposable test cartridges and can conceivably adapt to more than 250 medical and non-medical tests currently being conducted in laboratories.